Lemaitre Vascular (LMAT) Asset Writedowns and Impairment (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Asset Writedowns and Impairment of $362000.0 for Q4 2025, up 127.82% year-over-year from $158894.1 in Q4 2024, and up 162.96% quarter-over-quarter from -$575000.0 in Q3 2025.
Lemaitre Vascular (LMAT) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Asset Writedowns and Impairment for 16 consecutive years, with $362000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 127.82% year-over-year to $362000.0; the TTM figure through Mar 2026 stood at $180000.0 (down 75.48% YoY), while the FY2025 annual figure was $817000.0, changed 0.49% from the prior year.
- Asset Writedowns and Impairment advanced to $362000.0 in Q4 2025 per LMAT's latest filing, from -$575000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $2.2 million in Q4 2023 and bottomed at -$2.0 million in Q3 2021.
- Historically, Asset Writedowns and Impairment has averaged $238350.0 across 5 years, with a median of $391000.0 in 2022.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment sank 1220.47% — and 2024, when it soared 10328.57%.
- Lemaitre Vascular's Asset Writedowns and Impairment stood at $127000.0 in 2021, then tumbled by 1220.47% to -$1.4 million in 2022, then jumped by 252.99% to $2.2 million in 2023, then slumped by 159.76% to -$1.3 million in 2024, then soared by 127.82% to $362000.0 in 2025.
- Business Quant data shows LMAT's Asset Writedowns and Impairment at $362000.0 in Q4 2025, -$575000.0 in Q3 2025, and $393000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 787,000.00 |
| Jun 30, 2026 | 787,000.00 |
| Mar 31, 2026 | 761,000.00 |
| Mar 31, 2026 | 761,000.00 |
| Dec 31, 2025 | 362,000.00 |
| Dec 31, 2025 | 362,000.00 |
| Sep 30, 2025 | -575,000.00 |
| Sep 30, 2025 | -575,000.00 |
| Jun 30, 2025 | 393,000.00 |
| Jun 30, 2025 | 393,000.00 |
| Mar 31, 2025 | 637,000.00 |
| Mar 31, 2025 | 637,000.00 |
| Dec 31, 2024 | -1.30 Mn |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | 854,000.00 |
| Sep 30, 2024 | 854,000.00 |
| Jun 30, 2024 | 544,000.00 |
| Jun 30, 2024 | 544,000.00 |
| Mar 31, 2024 | 716,000.00 |
| Mar 31, 2024 | 716,000.00 |